Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.

Laboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with m...

Full description

Bibliographic Details
Main Authors: Katja Schmidt, Julia Butt, Petra Mauter, Klaus Vogel, Andrea Erles-Kemna, Michael Pawlita, Werner Nicklas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5663422?pdf=render
id doaj-8604de17b20a49e7a2027fc3350d8835
record_format Article
spelling doaj-8604de17b20a49e7a2027fc3350d88352020-11-25T01:30:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011210e018717410.1371/journal.pone.0187174Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.Katja SchmidtJulia ButtPetra MauterKlaus VogelAndrea Erles-KemnaMichael PawlitaWerner NicklasLaboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with murine astroviruses (MuAstV) were only recently discovered and are, therefore, still relatively unknown in laboratory animal science. In rodent health monitoring viral infections within a population are commonly assessed in terms of specific antibodies by serological testing, as active infection and excretion of virus is often temporary and can easily be missed. So far only ongoing infections with astroviruses can be detected by PCR. The objective of this work was the development of a sensitive and specific MuAstV multiplex serological assay with a high-throughput capability to be used in routine testing of laboratory mice. Four different MuAstV proteins were recombinantly expressed and used as antigens. The best reacting antigen, the capsid spike protein VP27, was selected and tested with a panel of 400 sera of mice from units with a known MuAstV status. Assay sensitivity and specificity resulted in 98.5% and 100%, respectively, compared to RT-PCR results. Eventually this assay was used to test 5529 serum samples in total, during routine diagnostics at the German Cancer Research Center (DKFZ) in Heidelberg between 2015 and 2017. High sero-prevalence rates of up to 98% were detected in units with open cages indicating that the virus is highly infectious and circulates within these populations virtually infecting all animals regardless of the mouse strain. In addition, data collected from 312 mice purchased from commercial breeders and from 661 mice from 58 research institutes in 15 countries worldwide allowed the conclusion that MuAstV is widespread in contemporary laboratory mouse populations.http://europepmc.org/articles/PMC5663422?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Katja Schmidt
Julia Butt
Petra Mauter
Klaus Vogel
Andrea Erles-Kemna
Michael Pawlita
Werner Nicklas
spellingShingle Katja Schmidt
Julia Butt
Petra Mauter
Klaus Vogel
Andrea Erles-Kemna
Michael Pawlita
Werner Nicklas
Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
PLoS ONE
author_facet Katja Schmidt
Julia Butt
Petra Mauter
Klaus Vogel
Andrea Erles-Kemna
Michael Pawlita
Werner Nicklas
author_sort Katja Schmidt
title Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
title_short Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
title_full Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
title_fullStr Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
title_full_unstemmed Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
title_sort development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2017-01-01
description Laboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with murine astroviruses (MuAstV) were only recently discovered and are, therefore, still relatively unknown in laboratory animal science. In rodent health monitoring viral infections within a population are commonly assessed in terms of specific antibodies by serological testing, as active infection and excretion of virus is often temporary and can easily be missed. So far only ongoing infections with astroviruses can be detected by PCR. The objective of this work was the development of a sensitive and specific MuAstV multiplex serological assay with a high-throughput capability to be used in routine testing of laboratory mice. Four different MuAstV proteins were recombinantly expressed and used as antigens. The best reacting antigen, the capsid spike protein VP27, was selected and tested with a panel of 400 sera of mice from units with a known MuAstV status. Assay sensitivity and specificity resulted in 98.5% and 100%, respectively, compared to RT-PCR results. Eventually this assay was used to test 5529 serum samples in total, during routine diagnostics at the German Cancer Research Center (DKFZ) in Heidelberg between 2015 and 2017. High sero-prevalence rates of up to 98% were detected in units with open cages indicating that the virus is highly infectious and circulates within these populations virtually infecting all animals regardless of the mouse strain. In addition, data collected from 312 mice purchased from commercial breeders and from 661 mice from 58 research institutes in 15 countries worldwide allowed the conclusion that MuAstV is widespread in contemporary laboratory mouse populations.
url http://europepmc.org/articles/PMC5663422?pdf=render
work_keys_str_mv AT katjaschmidt developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice
AT juliabutt developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice
AT petramauter developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice
AT klausvogel developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice
AT andreaerleskemna developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice
AT michaelpawlita developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice
AT wernernicklas developmentofamultiplexserologicalassayrevealsaworldwidedistributionofmurineastrovirusinfectionsinlaboratorymice
_version_ 1725089754644480000